Brook Byers
Founder
Brook Byers
Founder
Brook Byers has been a venture capital investor since 1972. He has been closely involved with founders to help build more than 60 new technology-based companies. He formed the first life sciences practice group in the venture capital profession in 1984 and led Kleiner Perkins to become a premier venture capital firm in the life sciences, healthcare and biotechnology sectors.
Brook was the founding president and then chairman of four biotechnology companies that were incubated in Kleiner Perkins’ offices and went on to become public companies with an aggregate market value of more than US$8 billion. He currently serves on the board of directors of Arsenal Bio, Octave Bio, Newsela and Verana Health. Brook serves on the board of the Stanford Center for BioDesign and is a Lifetime Board Member of the University of California San Francisco Medical Center. He served on the Board of Trustees of Stanford University, the Asian Art Museum in San Francisco and the Georgia Tech Advisory Board. He was also a founder of TechNet.
Raised in Atlanta, Georgia, Brook graduated with a bachelor’s degree in electrical engineering from Georgia Tech and received an M.B.A. from Stanford University. He received an Honorary PhD from Georgia Tech.
ArsenalBio
-
Partnered Since
2019 Early -
Stage
Growth -
Founders
Ken Drazen
-
Partners
Cell Design Labs
-
Partnered Since
2015 Early -
Stage
Acquired Gilead Sciences -
Partners
Crescendo Bioscience
-
Partnered Since
2018 Early -
Stage
Acquired Myriad Genetics -
Partners
Electronic Arts
-
Partnered Since
1982 Early -
Stage
IPO EA -
Partners
Foundation Medicine
-
Partnered Since
2011 Early -
Stage
IPO Acquired Roche -
Partners
Genentech
-
Partnered Since
1976 Early -
Stage
IPO Acquired Roche -
Founders
Herb Boyer Bob Swanson
-
Partners
Genomic Health
-
Partnered Since
2001 Early -
Stage
IPO Acquired Exact Sciences -
Partners
Newsela
-
Partnered Since
2015 Early -
Stage
Growth -
Founders
Dan Cogan-Drew Matthew Gross
-
Partners
Oculeve
-
Partnered Since
2011 Early -
Stage
Acquired Allergan -
Partners
OptiMedica
-
Partnered Since
2005 Early -
Stage
Acquired Abbott -
Partners
Pacific Biosciences of California
-
Partnered Since
2004 Early -
Stage
IPO PACB -
Partners
Veracyte
-
Partnered Since
2007 Early -
Stage
IPO VCYT -
Partners